Skip to content
Research Article Open access CC BY 4.0

Bacterial Profile and Antibiotic Susceptibility Patterns of Acute Exacerbation of Chronic Obstructive Pulmonary Disease in Assiut University Hospitals, Upper Egypt; a One-year Prospective Study

Mona Sallam Embarek Mohamed, Mohamed Ahmed El-Mokhtar, Alaa Thabet Hassan

Microbiology Research Journal International · pp. 288–305 · Published 10 Apr 2015

10.9734/BMRJ/2015/16317

Abstract

The majority of chronic obstructive pulmonary disease exacerbations are caused by infections of the tracheobronchial tree. Previous data on bacterial exacerbations of COPD in Upper Egypt are limited. Hence, this study was conducted for the identification of the causative bacteria in exacerbations of COPD, and to illustrate their antimicrobial susceptibility patterns at Assiut University Hospitals, Upper Egypt. A total of 116 COPD patients who underwent 167 infection exacerbation attacks participated in this prospective study during 2013. Significant bacterial growth was found in 143 (86%) out of the 167 exacerbation attacks. The most common detected bacteria were Haemophilus influenzae (19.4%), Escherichia coli (18%), Streptococcus pneumoniae (16.7%), Klebsiella pneumoniae (14%), Streptococcus pyogenes (10%), Pseudomonas aeruginosa (5.6%), methicillin resistant Staphylococcus aureus (5.6%), Acinetobacter baumannii (4.2%), and Moraxella catarrhalis (2.8%). The majority of the isolated strains showed high resistance rates to most groups of antibiotics where 91 (63%) of the isolated strains were multidrug resistant, 37 (26%) strains were extreme drug resistant and 16 (11%) bacterial strains were pandrug resistant. High resistance rates were observed against penicillins and cephalosporins. Moderate resistance rates were detected against the fluoroquinolones. High susceptibilities were detected to the carbapenem group. All the isolated Gram-positive bacteria were sensitive to linezolid.

Chronic obstructive pulmonary disease infection exacerbation antimicrobial resistance Upper Egypt

References (50)

  1. 1 Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance [DOI]
  2. 2 Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease [DOI]
  3. 3 Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease [DOI]
  4. 4 New Strains of Bacteria and Exacerbations of Chronic Obstructive Pulmonary Disease [DOI]
  5. 5 Toward a Consensus Definition for COPD Exacerbations [DOI]
  6. 6 COPD exacerbations: definitions and classifications [DOI]
  7. 7 Bacterial Infection in Chronic Obstructive Pulmonary Disease in 2000: a State-of-the-Art Review [DOI]
  8. 8 Airway and Systemic Inflammation and Decline in Lung Function in Patients With COPD [DOI]
  9. 9 Diagnosis and Management of Stable Chronic Obstructive Pulmonary Disease: A Clinical Practice Guideline from the American College of Physicians [DOI]
  10. 10 Outgrowth of the Bacterial Airway Microbiome after Rhinovirus Exacerbation of Chronic Obstructive Pulmonary Disease [DOI]
  11. 11 Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity [DOI]
  12. 12 Chronic obstructive pulmonary disease * 6: The aetiology of exacerbations of chronic obstructive pulmonary disease [DOI]
  13. 13 Seasonality and determinants of moderate and severe COPD exacerbations in the TORCH study [DOI]
  14. 14 Antibiotic use and resistance in emerging economies: a situation analysis for Viet Nam [DOI]
  15. 15 Association Between Pathogens Detected Using Quantitative Polymerase Chain Reaction With Airway Inflammation in COPD at Stable State and Exacerbations [DOI]
  16. 16 Adverse Effects of Corticosteroid Therapy for COPD [DOI]
  17. 17 Multiple-drug–resistant bacteria in patients with severe acute exacerbation of chronic obstructive pulmonary disease: Prevalence, risk factors, and outcome* [DOI]
  18. 18 Sputum induction as a research tool for sampling the airways of subjects with cystic fibrosis [DOI]
  19. 19 Does long-term oxygen therapy reduce hospitalisation in hypoxaemic chronic obstructive pulmonary disease? [DOI]
  20. 20 Sputum bacteriology in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease in Taiwan with an emphasis on Klebsiella pneumoniae and Pseudomonas aeruginosa [DOI]
  21. 21 Seasonal Distribution of COPD Exacerbations in the Prevention of Exacerbations With Tiotropium in COPD Trial [DOI]
  22. 22 Clinical presentation and predictors of outcome in patients with severe acute exacerbation of chronic obstructive pulmonary disease requiring admission to intensive care unit [DOI]
  23. 23 Protective Effect of Dl-3n-butylphthalide on Learning and Memory Impairment Induced by Chronic Intermittent Hypoxia-Hypercapnia Exposure [DOI]
  24. 24 Systematic review and meta‐analysis of studies involving telehome monitoring‐based telenursing for patients with chronic obstructive pulmonary disease [DOI]
  25. 25 Predictors of mortality of patients with acute respiratory failure secondary to chronic obstructive pulmonary disease admitted to an intensive care unit: A one year study [DOI]
  26. 26 Spectrum and antimicrobial resistance of common pathogenic bacteria isolated from patients with acute exacerbation of chronic obstructive pulmonary disease in mainland of China [DOI]
  27. 27 The Most Common Detected Bacteria in Sputum of Patients with the Acute Exacerbation of COPD [DOI]
  28. 28 Microbiological Diagnosis and Antibiotic Therapy in Patients with Community-Acquired Pneumonia and Acute COPD Exacerbation in Daily Clinical Practice: Comparison to Current Guidelines [DOI]
  29. 29 Influence of long-term smoking reduction on health risk markers and quality of life [DOI]
  30. 30 Host-Pathogen Interaction during Pneumococcal Infection in Patients with Chronic Obstructive Pulmonary Disease [DOI]
  31. 31 COPD: management of acute exacerbations and chronic stable disease.
  32. 32 BACTERIAL PROFILE, ANTIBIOTIC SENSITIVITY AND RESISTANCE OF LOWER RESPIRATORY TRACT INFECTIONS IN UPPER EGYPT [DOI]
  33. 33 Bacteriological Differences Between COPD Exacerbation and Community-Acquired Pneumonia [DOI]
  34. 34 Bacteriology in acute exacerbation of chronic obstructive pulmonary disease in patients admitted to hospital [DOI]
  35. 35 Epidemiology of infections caused by multidrug-resistant gram-negative bacteria in adult hospitalized patients at Siriraj Hospital.
  36. 36 Gram negative organisms as a cause of acute exacerbation of COPD [DOI]
  37. 37 Gram-negative bacilli causing infections in an intensive care unit of a tertiary care hospital in Istanbul, Turkey [DOI]
  38. 38 Antibiotic Therapy for Exacerbations of Chronic Obstructive Pulmonary Disease (COPD) [DOI]
  39. 39 A descriptive study of 42 cases of Branhamella catarrhalis pneumonia [DOI]
  40. 40 Optochin resistance inStreptococcus pneumoniae strains isolated from blood and middle ear fluid [DOI]
  41. 41 Microbiologic Spectrum and Antibiotic Susceptibility Pattern among Patients with Urinary and Respiratory Tract Infection [DOI]
  42. 42 Oral corticosteroids for exacerbations of chronic obstructive pulmonary disease [DOI]
  43. 43 COPD exacerbation: Lost in translation [DOI]
  44. 44 Activity of linezolid against multi-resistant Gram-positive bacteria from diverse hospitals in the United Kingdom [DOI]
  45. 45 What are the most appropriate antibiotics for the treatment of acute exacerbation of chronic obstructive pulmonary disease? A therapeutic outcomes model [DOI]
  46. 46 Emergence of Optochin Resistance among Streptococcus pneumoniae in Japan [DOI]
  47. 47 Frequency of Streptococcus pneumonia and Haemophilus influenza in acute exacerbation of chronic obstructive airway disease and their sensitivity to levofloxacin.
  48. 48 Original Research Article Bacterial agents causing acute exacerbations in Chronic Obstructive Pulmonary Disease (COPD) patients, their antibiograms to Extended Spectrum Beta- Lactamases (ESBL) production in a tertiary care hospital, India
  49. 49 Bacteria associated with acute exacerbations of chronic obstructive pulmonary disease requiring mechanical ventilation and antimicrobial management in Respiratory Care Unit of Central Chest Institute of Thailand.
  50. 50 A SIMPLE INDEX OF SMOKING

Cited by 9

Review and analysis of the overlapping threats of carbapenem and polymyxin resistant E. coli and Klebsiella in Africa

D. Venne, David M. Hartley, Marissa D. Malchione · Antimicrobial Resistance and Infection Control · 2023

Bacterial Profile and Antibiotics Susceptibility Pattern of Pleural Effusion Isolates from Sohag University Hospital

Ashraf Khodeary, Tamer Mohamed, K. Alkhayat · The Egyptian Journal of Medical Microbiology · 2022

Bacteriological Profile and its Antibiotic Sensitivity Pattern of Acute Exacerbation Chronic Obstructive Pulmonary Disease (AECOPD) Patients in Teritiary Care Hospital, Karimnagar, India

Aparna Bannaravuri, Amar C. Sajjan, G. Sowjanya · International Journal of Current Microbiology and Applied Sciences · 2019

MB1_OA_Nishant_2_5_6 RevC

Soniya Saxena, V. Ramnani, S. Nema · 2016

Showing 6 of 9 known citations — external sources report more than can currently be individually listed.

Article metrics

Real usage data collected on this platform.

79

Page views

0

PDF downloads

60

Outbound clicks

9

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.